title: A double-blind, placebo-controlled, phase-II clinical trial to evaluate oral simvastatin as a treatment for vitiligo.
authors.affiliation: Department of Medicine, Division of Dermatology, University of Massachusetts Medical School, Worcester, MA.
authors.forename: Stefan G
authors.initials: SG
authors.lastname: Vanderweil
authors.affiliation: Department of Medicine, Division of Dermatology, University of Massachusetts Medical School, Worcester, MA.
authors.forename: Shinya
authors.initials: S
authors.lastname: Amano
authors.affiliation: Department of Medicine, Division of Dermatology, University of Massachusetts Medical School, Worcester, MA.
authors.forename: Wei-Che
authors.initials: WC
authors.lastname: Ko
authors.affiliation: Department of Medicine, Division of Dermatology, University of Massachusetts Medical School, Worcester, MA.
authors.forename: Jillian M
authors.initials: JM
authors.lastname: Richmond
authors.affiliation: Department of Medicine, Division of Dermatology, University of Massachusetts Medical School, Worcester, MA.
authors.forename: Michelle
authors.initials: M
authors.lastname: Kelley
authors.affiliation: Department of Medicine, Division of Dermatology, University of Massachusetts Medical School, Worcester, MA.
authors.forename: Maryanne Makredes
authors.initials: MM
authors.lastname: Senna
authors.affiliation: Department of Medicine, Division of Dermatology, University of Massachusetts Medical School, Worcester, MA.
authors.forename: Andrea
authors.initials: A
authors.lastname: Pearson
authors.affiliation: Department of Medicine, Division of Dermatology, University of Massachusetts Medical School, Worcester, MA.
authors.forename: Sandhya
authors.initials: S
authors.lastname: Chowdary
authors.affiliation: Department of Medicine, Division of Dermatology, University of Massachusetts Medical School, Worcester, MA.
authors.forename: Celia
authors.initials: C
authors.lastname: Hartigan
authors.affiliation: Department of Medicine, Division of Dermatology, University of Massachusetts Medical School, Worcester, MA.
authors.forename: Bruce
authors.initials: B
authors.lastname: Barton
authors.affiliation: Department of Medicine, Division of Dermatology, University of Massachusetts Medical School, Worcester, MA. Electronic address: john.harris@umassmed.edu.
authors.forename: John E
authors.initials: JE
authors.lastname: Harris
mesh_terms: D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D001830:Body Surface Area; D054357:Chemokine CXCL10 / Q000097:blood; D004311:Double-Blind Method; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D012720:Severity of Illness Index; D019821:Simvastatin / Q000008:administration & dosage*; D016896:Treatment Outcome; D014820:Vitiligo / Q000097:blood / Q000188:drug therapy*; D055815:Young Adult
chemical_list: C114753:CXCL10 protein, human; D054357:Chemokine CXCL10; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D019821:Simvastatin